NCT06533787

Brief Summary

The goal of the study was to estimate the outcome (mortality and morbidity) among hemodynamically unstable neonates, as well as the time to return to hemodynamic stability following the use of ECHO in the management of hemodynamically unstable neonates.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 1, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

June 3, 2025

Status Verified

May 1, 2025

Enrollment Period

1 year

First QC Date

July 30, 2024

Last Update Submit

May 31, 2025

Conditions

Outcome Measures

Primary Outcomes (8)

  • Functional echocardiography ( ejection fraction using M mode echocardiography)

    Repeat echocardiographic assessment on a daily basis ( 24 hours interval)

  • Functional echocardiography fraction shortening by M mode echocardiography

    Repeat echocardiographic assessment on a daily basis ( 24 hours interval)

  • Assessment of ductus arteriosus ( diameter, shunt directionality ) by 2D and color doppler echocardiography

    Repeat echocardiographic assessment 5 days after the first echo assessment

  • Assessment of pulmonary hypertension

    Using peak tricuspid regurgitation velocity by colour doppler

    Repeat echocardiographic assessment on a daily basis ( 24 hours interval) following proposed treatment of pulmonary hypertension

  • Assessment of LV cardiac index

    Assessment of LV outflow tract diameter by 2D/M mode echocardiography in parasternal long axis view and assessment of Velocity-time integral of PW in LV outflow tract by PW doppler in apical five-chamber view

    Repeat echocardiographic assessment on a daily basis ( 24 hours interval)

  • Assessment of RV cardiac index

    Assessment of RV outflow tract diameter by 2D echocardiography and Velocity-time integral of PW in RV outflow tract

    Repeat echocardiographic assessment on a daily basis ( 24 hours interval)

  • Assessment of SVC flow

    Assessment of SVC diameter (mean of systolic and diastolic diameter) by M mode echocardiography in high parasternal view

    Repeat echocardiographic assessment on a daily basis ( 24 hours interval)

  • Assessment of RV function

    Measurement of Tricuspid annular plane systolic excursion (TAPSE) using M mode echocardiography in apical four chamber view

    Repeat echocardiographic assessment on a daily basis ( 24 hours interval)

Study Arms (2)

Group 1

Hemodynamically unstable neonates

Device: Echocardiography

Group 2

Hemodynamically stable neonates

Device: Echocardiography

Interventions

Functional echocardiography assessment

Group 1Group 2

Eligibility Criteria

Age2 Hours - 28 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Neonates ( age 0 to 28 days) admitted to the NICU of Sohag University Hospital during the period of the study

You may qualify if:

  • All neonates ( age 0 to 28 days) admitted to the NICU of Sohag University Hospital during the period of the study in whom manifestations of hemodynamic instability or critical illness were elected regardless of gestational age, weight, gender, or type of disease.

You may not qualify if:

  • Failure to obtain informed consent .
  • Presence of congenital heart disease apart from PDA , PFO \& small ASD .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University Hospital

Sohag, Egypt

RECRUITING

Related Publications (7)

  • Kluckow M, Seri I, Evans N. Functional echocardiography: an emerging clinical tool for the neonatologist. J Pediatr. 2007 Feb;150(2):125-30. doi: 10.1016/j.jpeds.2006.10.056. No abstract available.

    PMID: 17236886BACKGROUND
  • Soleymani S, Borzage M, Seri I. Hemodynamic monitoring in neonates: advances and challenges. J Perinatol. 2010 Oct;30 Suppl:S38-45. doi: 10.1038/jp.2010.101.

    PMID: 20877406BACKGROUND
  • Tibby SM, Hatherill M, Marsh MJ, Murdoch IA. Clinicians' abilities to estimate cardiac index in ventilated children and infants. Arch Dis Child. 1997 Dec;77(6):516-8. doi: 10.1136/adc.77.6.516.

    PMID: 9496187BACKGROUND
  • Egan JR, Festa M, Cole AD, Nunn GR, Gillis J, Winlaw DS. Clinical assessment of cardiac performance in infants and children following cardiac surgery. Intensive Care Med. 2005 Apr;31(4):568-73. doi: 10.1007/s00134-005-2569-5. Epub 2005 Feb 15.

    PMID: 15711976BACKGROUND
  • de Boode WP. Clinical monitoring of systemic hemodynamics in critically ill newborns. Early Hum Dev. 2010 Mar;86(3):137-41. doi: 10.1016/j.earlhumdev.2010.01.031. Epub 2010 Feb 20.

    PMID: 20171815BACKGROUND
  • McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed. 2007 Nov;92(6):F424-7. doi: 10.1136/adc.2007.118117.

    PMID: 17951547BACKGROUND
  • Sehgal A, McNamara PJ. Does point-of-care functional echocardiography enhance cardiovascular care in the NICU? J Perinatol. 2008 Nov;28(11):729-35. doi: 10.1038/jp.2008.100. Epub 2008 Jul 17.

    PMID: 18633423BACKGROUND

MeSH Terms

Conditions

Critical Illness

Interventions

Echocardiography

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonographyHeart Function TestsDiagnostic Techniques, Cardiovascular

Central Study Contacts

Sahar Abuzakaly Mahmoud, MBBS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Resident doctor of pediatrics at Sohag university hospital

Study Record Dates

First Submitted

July 30, 2024

First Posted

August 1, 2024

Study Start

August 1, 2024

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

June 3, 2025

Record last verified: 2025-05

Locations